Pre-order Enquiry
Request Free Sample
Global and Japan G-CSF and G-CSF Biosimilars Market Insights, Forecast to 2026
SKU ID : QYR-16365216 | Publishing Date : 03-Sep-2020 | No. of pages : 140
Request Sample
Request Customization
Check DiscountsDetailed TOC of Global and Japan G-CSF and G-CSF Biosimilars Market Insights, Forecast to 2026
1 Study Coverage1.1 G-CSF and G-CSF Biosimilars Product Introduction
1.2 Market Segments
1.3 Key G-CSF and G-CSF Biosimilars Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Type
1.4.2 Blood Disorders
1.4.3 Oncology Diseases
1.4.4 Chronic And Autoimmune Diseases
1.4.5 Growth Hormone Deficiencies
1.5 Market by Application
1.5.1 Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Application
1.5.2 Human Growth Hormone
1.5.3 Erythropoietin
1.5.4 Monoclonal Antibodies
1.5.5 Insulin
1.5.6 Interferon
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global G-CSF and G-CSF Biosimilars Market Size, Estimates and Forecasts
2.1.1 Global G-CSF and G-CSF Biosimilars Revenue 2015-2026
2.1.2 Global G-CSF and G-CSF Biosimilars Sales 2015-2026
2.2 Global G-CSF and G-CSF Biosimilars, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 G-CSF and G-CSF Biosimilars Historical Market Size by Region (2015-2020)
2.3.1 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Sales by Region: 2015-2020
2.3.2 Global G-CSF and G-CSF Biosimilars Retrospective Market Scenario in Revenue by Region: 2015-2020
2.4 G-CSF and G-CSF Biosimilars Market Estimates and Projections by Region (2021-2026)
2.4.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Region (2021-2026)
2.4.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Region (2021-2026)
3 Global G-CSF and G-CSF Biosimilars Competitor Landscape by Players
3.1 Global Top G-CSF and G-CSF Biosimilars Sales by Manufacturers
3.1.1 Global G-CSF and G-CSF Biosimilars Sales by Manufacturers (2015-2020)
3.1.2 Global G-CSF and G-CSF Biosimilars Sales Market Share by Manufacturers (2015-2020)
3.2 Global G-CSF and G-CSF Biosimilars Manufacturers by Revenue
3.2.1 Global G-CSF and G-CSF Biosimilars Revenue by Manufacturers (2015-2020)
3.2.2 Global G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers (2015-2020)
3.2.3 Global G-CSF and G-CSF Biosimilars Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by G-CSF and G-CSF Biosimilars Revenue in 2019
3.2.5 Global G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global G-CSF and G-CSF Biosimilars Price by Manufacturers
3.4 Global G-CSF and G-CSF Biosimilars Manufacturing Base Distribution, Product Types
3.4.1 G-CSF and G-CSF Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers G-CSF and G-CSF Biosimilars Product Type
3.4.3 Date of International Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global G-CSF and G-CSF Biosimilars Market Size by Type (2015-2020)
4.1.1 Global G-CSF and G-CSF Biosimilars Sales by Type (2015-2020)
4.1.2 Global G-CSF and G-CSF Biosimilars Revenue by Type (2015-2020)
4.1.3 G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Type (2015-2026)
4.2 Global G-CSF and G-CSF Biosimilars Market Size Forecast by Type (2021-2026)
4.2.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Type (2021-2026)
4.2.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Type (2021-2026)
4.2.3 G-CSF and G-CSF Biosimilars Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global G-CSF and G-CSF Biosimilars Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global G-CSF and G-CSF Biosimilars Market Size by Application (2015-2020)
5.1.1 Global G-CSF and G-CSF Biosimilars Sales by Application (2015-2020)
5.1.2 Global G-CSF and G-CSF Biosimilars Revenue by Application (2015-2020)
5.1.3 G-CSF and G-CSF Biosimilars Price by Application (2015-2020)
5.2 G-CSF and G-CSF Biosimilars Market Size Forecast by Application (2021-2026)
5.2.1 Global G-CSF and G-CSF Biosimilars Sales Forecast by Application (2021-2026)
5.2.2 Global G-CSF and G-CSF Biosimilars Revenue Forecast by Application (2021-2026)
5.2.3 Global G-CSF and G-CSF Biosimilars Price Forecast by Application (2021-2026)
6 Japan by Players, Type and Application
6.1 Japan G-CSF and G-CSF Biosimilars Market Size YoY Growth 2015-2026
6.1.1 Japan G-CSF and G-CSF Biosimilars Sales YoY Growth 2015-2026
6.1.2 Japan G-CSF and G-CSF Biosimilars Revenue YoY Growth 2015-2026
6.1.3 Japan G-CSF and G-CSF Biosimilars Market Share in Global Market 2015-2026
6.2 Japan G-CSF and G-CSF Biosimilars Market Size by Players (International and Local Players)
6.2.1 Japan Top G-CSF and G-CSF Biosimilars Players by Sales (2015-2020)
6.2.2 Japan Top G-CSF and G-CSF Biosimilars Players by Revenue (2015-2020)
6.3 Japan G-CSF and G-CSF Biosimilars Historic Market Review by Type (2015-2020)
6.3.1 Japan G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
6.3.2 Japan G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2015-2020)
6.3.3 Japan G-CSF and G-CSF Biosimilars Price by Type (2015-2020)
6.4 Japan G-CSF and G-CSF Biosimilars Market Estimates and Forecasts by Type (2021-2026)
6.4.1 Japan G-CSF and G-CSF Biosimilars Sales Forecast by Type (2021-2026)
6.4.2 Japan G-CSF and G-CSF Biosimilars Revenue Forecast by Type (2021-2026)
6.4.3 Japan G-CSF and G-CSF Biosimilars Price Forecast by Type (2021-2026)
6.5 Japan G-CSF and G-CSF Biosimilars Historic Market Review by Application (2015-2020)
6.5.1 Japan G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
6.5.2 Japan G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2015-2020)
6.5.3 Japan G-CSF and G-CSF Biosimilars Price by Application (2015-2020)
6.6 Japan G-CSF and G-CSF Biosimilars Market Estimates and Forecasts by Application (2021-2026)
6.6.1 Japan G-CSF and G-CSF Biosimilars Sales Forecast by Application (2021-2026)
6.6.2 Japan G-CSF and G-CSF Biosimilars Revenue Forecast by Application (2021-2026)
6.6.3 Japan G-CSF and G-CSF Biosimilars Price Forecast by Application (2021-2026)
7 North America
7.1 North America G-CSF and G-CSF Biosimilars Market Size YoY Growth 2015-2026
7.2 North America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
7.2.1 North America G-CSF and G-CSF Biosimilars Sales by Country (2015-2020)
7.2.2 North America G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020)
7.2.3 U.S.
7.2.4 Canada
8 Europe
8.1 Europe G-CSF and G-CSF Biosimilars Market Size YoY Growth 2015-2026
8.2 Europe G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
8.2.1 Europe G-CSF and G-CSF Biosimilars Sales by Country
8.2.2 Europe G-CSF and G-CSF Biosimilars Revenue by Country
8.2.3 Germany
8.2.4 France
8.2.5 U.K.
8.2.6 Italy
8.2.7 Russia
9 Asia Pacific
9.1 Asia Pacific G-CSF and G-CSF Biosimilars Market Size YoY Growth 2015-2026
9.2 Asia Pacific G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
9.2.1 Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region (2015-2020)
9.2.2 Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region
9.2.3 China
9.2.4 Japan
9.2.5 South Korea
9.2.6 India
9.2.7 Australia
9.2.8 Taiwan
9.2.9 Indonesia
9.2.10 Thailand
9.2.11 Malaysia
9.2.12 Philippines
9.2.13 Vietnam
10 Latin America
10.1 Latin America G-CSF and G-CSF Biosimilars Market Size YoY Growth 2015-2026
10.2 Latin America G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
10.2.1 Latin America G-CSF and G-CSF Biosimilars Sales by Country
10.2.2 Latin America G-CSF and G-CSF Biosimilars Revenue by Country
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa G-CSF and G-CSF Biosimilars Market Size YoY Growth 2015-2026
11.2 Middle East and Africa G-CSF and G-CSF Biosimilars Market Facts & Figures by Country
11.2.1 Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country
11.2.2 Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 U.A.E
12 Company Profiles
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Description and Business Overview
12.1.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer G-CSF and G-CSF Biosimilars Products Offered
12.1.5 Pfizer Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Description and Business Overview
12.2.3 Novartis Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Novartis G-CSF and G-CSF Biosimilars Products Offered
12.2.5 Novartis Recent Development
12.3 Roche
12.3.1 Roche Corporation Information
12.3.2 Roche Description and Business Overview
12.3.3 Roche Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Roche G-CSF and G-CSF Biosimilars Products Offered
12.3.5 Roche Recent Development
12.4 Merck & Co.
12.4.1 Merck & Co. Corporation Information
12.4.2 Merck & Co. Description and Business Overview
12.4.3 Merck & Co. Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Merck & Co. G-CSF and G-CSF Biosimilars Products Offered
12.4.5 Merck & Co. Recent Development
12.5 Sanofi
12.5.1 Sanofi Corporation Information
12.5.2 Sanofi Description and Business Overview
12.5.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sanofi G-CSF and G-CSF Biosimilars Products Offered
12.5.5 Sanofi Recent Development
12.6 Johnson & Johnson
12.6.1 Johnson & Johnson Corporation Information
12.6.2 Johnson & Johnson Description and Business Overview
12.6.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Johnson & Johnson G-CSF and G-CSF Biosimilars Products Offered
12.6.5 Johnson & Johnson Recent Development
12.7 Gilead Science
12.7.1 Gilead Science Corporation Information
12.7.2 Gilead Science Description and Business Overview
12.7.3 Gilead Science Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Gilead Science G-CSF and G-CSF Biosimilars Products Offered
12.7.5 Gilead Science Recent Development
12.8 GlaxoSmithKline
12.8.1 GlaxoSmithKline Corporation Information
12.8.2 GlaxoSmithKline Description and Business Overview
12.8.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
12.8.4 GlaxoSmithKline G-CSF and G-CSF Biosimilars Products Offered
12.8.5 GlaxoSmithKline Recent Development
12.9 AbbVie
12.9.1 AbbVie Corporation Information
12.9.2 AbbVie Description and Business Overview
12.9.3 AbbVie Sales, Revenue and Gross Margin (2015-2020)
12.9.4 AbbVie G-CSF and G-CSF Biosimilars Products Offered
12.9.5 AbbVie Recent Development
12.10 Amgen
12.10.1 Amgen Corporation Information
12.10.2 Amgen Description and Business Overview
12.10.3 Amgen Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Amgen G-CSF and G-CSF Biosimilars Products Offered
12.10.5 Amgen Recent Development
12.11 Pfizer
12.11.1 Pfizer Corporation Information
12.11.2 Pfizer Description and Business Overview
12.11.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Pfizer G-CSF and G-CSF Biosimilars Products Offered
12.11.5 Pfizer Recent Development
12.12 Bayer
12.12.1 Bayer Corporation Information
12.12.2 Bayer Description and Business Overview
12.12.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Bayer Products Offered
12.12.5 Bayer Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key G-CSF and G-CSF Biosimilars Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 G-CSF and G-CSF Biosimilars Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and Japan G-CSF and G-CSF Biosimilars Market Insights, Forecast to 2026
List of TablesTable 1. G-CSF and G-CSF Biosimilars Market Segments
Table 2. Ranking of Global Top G-CSF and G-CSF Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Blood Disorders
Table 5. Major Manufacturers of Oncology Diseases
Table 6. Major Manufacturers of Chronic And Autoimmune Diseases
Table 7. Major Manufacturers of Growth Hormone Deficiencies
Table 8. Global G-CSF and G-CSF Biosimilars Market Size Growth Rate by Application 2020-2026 (K Units)
Table 9. Global G-CSF and G-CSF Biosimilars Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 10. Global G-CSF and G-CSF Biosimilars Sales by Regions 2015-2020 (K Units)
Table 11. Global G-CSF and G-CSF Biosimilars Sales Market Share by Regions (2015-2020)
Table 12. Global G-CSF and G-CSF Biosimilars Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global G-CSF and G-CSF Biosimilars Sales Forecast by Region (2021-2026) (K Units)
Table 14. Global G-CSF and G-CSF Biosimilars Sales by Manufacturers (2015-2020) (K Units)
Table 15. Global G-CSF and G-CSF Biosimilars Sales Share by Manufacturers (2015-2020)
Table 16. Global G-CSF and G-CSF Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global G-CSF and G-CSF Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in G-CSF and G-CSF Biosimilars as of 2019)
Table 18. G-CSF and G-CSF Biosimilars Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. G-CSF and G-CSF Biosimilars Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers G-CSF and G-CSF Biosimilars Price (2015-2020) (USD/Unit)
Table 21. G-CSF and G-CSF Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers G-CSF and G-CSF Biosimilars Product Type
Table 23. Date of International Manufacturers Enter into G-CSF and G-CSF Biosimilars Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global G-CSF and G-CSF Biosimilars Sales by Type (2015-2020) (K Units)
Table 26. Global G-CSF and G-CSF Biosimilars Sales Share by Type (2015-2020)
Table 27. Global G-CSF and G-CSF Biosimilars Revenue by Type (2015-2020) (US$ Million)
Table 28. Global G-CSF and G-CSF Biosimilars Revenue Share by Type (2015-2020)
Table 29. G-CSF and G-CSF Biosimilars Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)
Table 30. Global G-CSF and G-CSF Biosimilars Sales Share by Type (2021-2026)
Table 31. Global G-CSF and G-CSF Biosimilars Sales by Application (2015-2020) (K Units)
Table 32. Global G-CSF and G-CSF Biosimilars Sales Share by Application (2015-2020)
Table 33. Global G-CSF and G-CSF Biosimilars Sales Share by Application (2021-2026)
Table 34. Global G-CSF and G-CSF Biosimilars Sales Market Share Forecast by Application (2021-2026)
Table 35. Global G-CSF and G-CSF Biosimilars Revenue by Application (2015-2020) (US$ Million)
Table 36. Global G-CSF and G-CSF Biosimilars Revenue Market Share Forecast by Application (2021-2026)
Table 37. Japan G-CSF and G-CSF Biosimilars Sales (K Units) of Key Companies (2015-2020)
Table 38. Japan G-CSF and G-CSF Biosimilars Sales Share by Company (2015-2020)
Table 39. Japan G-CSF and G-CSF Biosimilars Revenue (US$ Million) by Company (2015-2020)
Table 40. Japan G-CSF and G-CSF Biosimilars Sales (K Units) by Type (2015-2020)
Table 41. Japan G-CSF and G-CSF Biosimilars Sales Share by Type (2015-2020)
Table 42. Japan G-CSF and G-CSF Biosimilars Revenue (US$ Million) Market Share by Type (2015-2020)
Table 43. Japan G-CSF and G-CSF Biosimilars Price (K Units) by Type (2015-2020)
Table 44. Japan G-CSF and G-CSF Biosimilars Sales (K Units) by Type (2021-2026)
Table 45. Japan G-CSF and G-CSF Biosimilars Sales Share by Type (2021-2026)
Table 46. Japan G-CSF and G-CSF Biosimilars Revenue (US$ Million) Market Share by Type (2021-2026)
Table 47. Japan G-CSF and G-CSF Biosimilars Revenue Share by Type (2021-2026)
Table 48. Japan G-CSF and G-CSF Biosimilars Price (K Units) by Type (2021-2026)
Table 49. Japan G-CSF and G-CSF Biosimilars Sales (K Units) by Application (2015-2020)
Table 50. Japan G-CSF and G-CSF Biosimilars Sales Share by Application (2015-2020)
Table 51. Japan G-CSF and G-CSF Biosimilars Revenue (US$ Million) Market Share by Application (2015-2020)
Table 52. Japan G-CSF and G-CSF Biosimilars Sales (K Units) by Application (2021-2026)
Table 53. Japan G-CSF and G-CSF Biosimilars Sales Share by Application (2021-2026)
Table 54. Japan G-CSF and G-CSF Biosimilars Revenue (US$ Million) Market Share by Application (2021-2026)
Table 55. Japan G-CSF and G-CSF Biosimilars Revenue Share by Application (2021-2026)
Table 56. North America G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 57. North America G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 58. North America G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 59. North America G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 60. Europe G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 61. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 62. Europe G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 63. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 64. Asia Pacific G-CSF and G-CSF Biosimilars Sales by Region (2015-2020) (K Units)
Table 65. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Region (2015-2020)
Table 66. Asia Pacific G-CSF and G-CSF Biosimilars Revenue by Region (2015-2020) (US$ Million)
Table 67. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2015-2020)
Table 68. Latin America G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 69. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 70. Latin Americaa G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 71. Latin America G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 72. Middle East and Africa G-CSF and G-CSF Biosimilars Sales by Country (2015-2020) (K Units)
Table 73. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Country (2015-2020)
Table 74. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue by Country (2015-2020) (US$ Million)
Table 75. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Country (2015-2020)
Table 76. Pfizer Corporation Information
Table 77. Pfizer Description and Business Overview
Table 78. Pfizer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 79. Pfizer G-CSF and G-CSF Biosimilars Product
Table 80. Pfizer Recent Development
Table 81. Novartis Corporation Information
Table 82. Novartis Description and Business Overview
Table 83. Novartis G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 84. Novartis Product
Table 85. Novartis Recent Development
Table 86. Roche Corporation Information
Table 87. Roche Description and Business Overview
Table 88. Roche G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 89. Roche Product
Table 90. Roche Recent Development
Table 91. Merck & Co. Corporation Information
Table 92. Merck & Co. Description and Business Overview
Table 93. Merck & Co. G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 94. Merck & Co. Product
Table 95. Merck & Co. Recent Development
Table 96. Sanofi Corporation Information
Table 97. Sanofi Description and Business Overview
Table 98. Sanofi G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 99. Sanofi Product
Table 100. Sanofi Recent Development
Table 101. Johnson & Johnson Corporation Information
Table 102. Johnson & Johnson Description and Business Overview
Table 103. Johnson & Johnson G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 104. Johnson & Johnson Product
Table 105. Johnson & Johnson Recent Development
Table 106. Gilead Science Corporation Information
Table 107. Gilead Science Description and Business Overview
Table 108. Gilead Science G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 109. Gilead Science Product
Table 110. Gilead Science Recent Development
Table 111. GlaxoSmithKline Corporation Information
Table 112. GlaxoSmithKline Description and Business Overview
Table 113. GlaxoSmithKline G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. GlaxoSmithKline Product
Table 115. GlaxoSmithKline Recent Development
Table 116. AbbVie Corporation Information
Table 117. AbbVie Description and Business Overview
Table 118. AbbVie G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 119. AbbVie Product
Table 120. AbbVie Recent Development
Table 121. Amgen Corporation Information
Table 122. Amgen Description and Business Overview
Table 123. Amgen G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 124. Amgen Product
Table 125. Amgen Recent Development
Table 126. AstraZeneca Corporation Information
Table 127. AstraZeneca Description and Business Overview
Table 128. AstraZeneca G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 129. AstraZeneca Product
Table 130. AstraZeneca Recent Development
Table 131. Bayer Corporation Information
Table 132. Bayer Description and Business Overview
Table 133. Bayer G-CSF and G-CSF Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 134. Bayer Product
Table 135. Bayer Recent Development
Table 136. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 137. Key Challenges
Table 138. Market Risks
Table 139. Main Points Interviewed from Key G-CSF and G-CSF Biosimilars Players
Table 140. G-CSF and G-CSF Biosimilars Customers List
Table 141. G-CSF and G-CSF Biosimilars Distributors List
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. G-CSF and G-CSF Biosimilars Product Picture
Figure 2. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type in 2020 & 2026
Figure 3. Blood Disorders Product Picture
Figure 4. Oncology Diseases Product Picture
Figure 5. Chronic And Autoimmune Diseases Product Picture
Figure 6. Growth Hormone Deficiencies Product Picture
Figure 7. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application in 2020 & 2026
Figure 8. Human Growth Hormone
Figure 9. Erythropoietin
Figure 10. Monoclonal Antibodies
Figure 11. Insulin
Figure 12. Interferon
Figure 13. G-CSF and G-CSF Biosimilars Report Years Considered
Figure 14. Global G-CSF and G-CSF Biosimilars Market Size 2015-2026 (US$ Million)
Figure 15. Global G-CSF and G-CSF Biosimilars Sales 2015-2026 (K Units)
Figure 16. Global G-CSF and G-CSF Biosimilars Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region (2015-2020)
Figure 18. Global G-CSF and G-CSF Biosimilars Sales Market Share by Region in 2019
Figure 19. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region (2015-2020)
Figure 20. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Region in 2019
Figure 21. Global G-CSF and G-CSF Biosimilars Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by G-CSF and G-CSF Biosimilars Revenue in 2019
Figure 23. G-CSF and G-CSF Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type (2015-2020)
Figure 25. Global G-CSF and G-CSF Biosimilars Sales Market Share by Type in 2019
Figure 26. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type (2015-2020)
Figure 27. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Type in 2019
Figure 28. Global G-CSF and G-CSF Biosimilars Market Share by Price Range (2015-2020)
Figure 29. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application (2015-2020)
Figure 30. Global G-CSF and G-CSF Biosimilars Sales Market Share by Application in 2019
Figure 31. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application (2015-2020)
Figure 32. Global G-CSF and G-CSF Biosimilars Revenue Market Share by Application in 2019
Figure 33. Japan G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2026 (K Units)
Figure 34. Japan G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2026 (US$ Million)
Figure 35. Japan G-CSF and G-CSF Biosimilars Market Share in Global Market 2015-2026
Figure 36. Japan 5 and 10 Largest G-CSF and G-CSF Biosimilars Players Market Share by Revenue in G-CSF and G-CSF Biosimilars in 2019
Figure 37. Japan G-CSF and G-CSF Biosimilars Revenue Share by Type (2015-2020)
Figure 38. Japan G-CSF and G-CSF Biosimilars Revenue Growth Rate by Type in 2015 & 2019
Figure 39. Japan G-CSF and G-CSF Biosimilars Revenue Share by Application (2015-2020)
Figure 40. Japan G-CSF and G-CSF Biosimilars Revenue Growth Rate by Application in 2015 & 2019
Figure 41. North America G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 42. North America G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 43. North America G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 44. North America G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 45. U.S. G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 46. U.S. G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. Canada G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 48. Canada G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Europe G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 50. Europe G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 51. Europe G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 52. Europe G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 53. Germany G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 54. Germany G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. France G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 56. France G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. U.K. G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 58. U.K. G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Italy G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 60. Italy G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Russia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 62. Russia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Asia Pacific G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 64. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 65. Asia Pacific G-CSF and G-CSF Biosimilars Sales Market Share by Region in 2019
Figure 66. Asia Pacific G-CSF and G-CSF Biosimilars Revenue Market Share by Region in 2019
Figure 67. China G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 68. China G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Japan G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 70. Japan G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. South Korea G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 72. South Korea G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. India G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 74. India G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Australia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 76. Australia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Taiwan G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 78. Taiwan G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Indonesia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 80. Indonesia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Thailand G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 82. Thailand G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Malaysia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 84. Malaysia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Philippines G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 86. Philippines G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 87. Vietnam G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 88. Vietnam G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 89. Latin America G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 90. Latin America G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 91. Latin America G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 92. Latin America G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 93. Mexico G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 94. Mexico G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Brazil G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 96. Brazil G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Argentina G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 98. Argentina G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 99. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Growth Rate 2015-2020 (K Units)
Figure 100. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa G-CSF and G-CSF Biosimilars Sales Market Share by Country in 2019
Figure 102. Middle East and Africa G-CSF and G-CSF Biosimilars Revenue Market Share by Country in 2019
Figure 103. Turkey G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 104. Turkey G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 106. Saudi Arabia G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E G-CSF and G-CSF Biosimilars Sales Growth Rate (2015-2020) (K Units)
Figure 108. U.A.E G-CSF and G-CSF Biosimilars Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Porter's Five Forces Analysis
Figure 110. G-CSF and G-CSF Biosimilars Value Chain
Figure 111. Channels of Distribution
Figure 112. Distributors Profiles
Figure 113. Bottom-up and Top-down Approaches for This Report
Figure 114. Data Triangulation
Figure 115. Key Executives Interviewed
Keyplayers in Global and Japan G-CSF and G-CSF Biosimilars Market Insights, Forecast to 2026
PfizerNovartis
Roche
Merck & Co.
Sanofi
Johnson & Johnson
Gilead Science
GlaxoSmithKline
AbbVie
Amgen
AstraZeneca
Bayer
